Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AL › Tuscaloosa › NPI 1366408502
Physician

Emergi-Care Clinici, P.C.

Emergi-Care Clinici, P.C. was paid $95K by Medicaid between Jan 2018 and Dec 2023, across 9 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 71% of everything it billed.

33Billing provider infoEMERGI-CARE CLINICI, P.C.
TUSCALOOSA, AL 35404
33aNPI1366408502assigned 04/25/2006
28Total paid$95K
24GClaims2,599
24DCodes billed9
24AFirst – last monthJan 2018 – Dec 2023
Compared with peers

Next to other Emergency Medicine Physician providers in Alabama

Rank by total paid#65 of 105
Median peer was paid$247K
This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.5K$5.0K$7.5K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018375$19K
2019810$22K
2020269$7K
2021251$8K
2022538$21K
2023356$18K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 71% 844 764 $67K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 12% 570 548 $11K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.6% 90 86 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 4.2% 185 180 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3.7% 329 321 $4K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2.9% 47 46 $3K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.1% 43 41 $1K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 475 460 $724.42
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 16 15 $375.36

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOBO, PHILLIP (PRESIDENT/OWNER)